Skip to main navigation Skip to search Skip to main content

Molecular profiling of cutaneous lupus lesions identifies subgroups distinct from clinical phenotypes

  • Celine C. Berthier
  • , Lam C. Tsoi
  • , Tamra J. Reed
  • , Jasmine N. Stannard
  • , Emily M. Myers
  • , Rajaie Namas
  • , Xianying Xing
  • , Stephanie Lazar
  • , Lori Lowe
  • , Matthias Kretzler
  • , Johann E. Gudjonsson
  • , J. Michelle Kahlenberg
  • University of Michigan, Ann Arbor
  • IHA Rheumatology Consultants
  • LifeBridge Health

Research output: Contribution to journal › Article › peer-review

57 Scopus citations

Abstract

Cutaneous lupus erythematosus (CLE) is a common manifestation of systemic lupus erythematosus (SLE), and CLE can also develop without systemic involvement. CLE can be difficult to treat and negatively contributes to quality of life. Despite the importance of CLE, our knowledge of what differentiates cutaneous lupus subtypes is limited. Here, we utilized a large cohort of 90 CLE lesional biopsies to compare discoid lupus erythematosus (DLE) and subacute cutaneous lupus (SCLE) in patients with and without associated SLE in order to discern the drivers of disease activity and possibly uncover better treatment targets. Overall, we found that DLE and SCLE share many differentially expressed genes (DEG) reflecting type I interferon (IFN) signaling and repression of EGFR pathways. No differences between CLE only and SLE-associated CLE lesions were found. Of note, DLE uniquely expresses an IFN-γ node. Unbiased cluster analysis of the DEGs identified two groups separated by neutrophilic vs. monocytic signatures that did not sort the patients based on clinical phenotype or disease activity. This suggests that unbiased analysis of the pathobiology of CLE lesions may be important for personalized medicine and targeted therapeutic decision making.

Original languageEnglish
Article number1244
JournalJournal of Clinical Medicine
Volume8
Issue number8
DOIs
StatePublished - Aug 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Cutaneous lupus
  • Discoid
  • Interferon
  • Systemic lupus erythematosus

Fingerprint

Dive into the research topics of 'Molecular profiling of cutaneous lupus lesions identifies subgroups distinct from clinical phenotypes'. Together they form a unique fingerprint.

Cite this